Pulmonary Artery Catheter (Swan-Ganz): Design, Indications, and Cardiac Output Measurement

The standard pulmonary artery catheter is a 7-French (2.3 mm external diameter), 110-cm polyvinyl chloride catheter with four primary lumens and a distal balloon. The distal (PA) lumen opens at the catheter tip and is used for continuous pulmonary artery pressure monitoring and mixed venous blood sampling. The proximal lumen exits approximately 30 cm from the tip and, when properly positioned, resides in the right atrium for central venous pressure measurement, fluid infusion, and cold saline injection during thermodilution cardiac output determinations. A balloon inflation lumen connects to a 1.5 mL latex balloon at the tip, which is inflated during catheter advancement and for obtaining the pulmonary capillary wedge pressure.

A thermistor located 3.7 cm proximal to the catheter tip measures blood temperature changes used to calculate thermodilution cardiac output. When cold saline (typically 10 mL of room-temperature or iced normal saline) is injected through the proximal port, the thermistor detects the resulting temperature deflection as the injectate mixes with blood flowing past the catheter tip. The area under the resulting time-temperature curve is inversely proportional to cardiac output, computed by the modified Stewart-Hamilton equation. Some advanced PAC models include a fifth VIP (venous infusion port) lumen for medication delivery and an additional RV port for RV pressure monitoring or pacing.

Modern PAC variants incorporate continuous cardiac output (CCO) technology using a thermal filament that emits low-energy heat pulses into the surrounding blood, generating a continuous thermodilution signal processed by a bedside computer. Additionally, fiber-optic PA catheters provide continuous mixed venous oxygen saturation (SvO₂) monitoring through reflectance spectrophotometry, enabling real-time assessment of the balance between oxygen delivery and consumption. These technological advances have transformed the PAC from a purely diagnostic tool into a continuous hemodynamic monitoring platform, though the fundamental physics of flow-directed catheter design remains unchanged since the original Swan-Ganz innovation.

PA catheter placement is indicated when precise hemodynamic data are needed to guide clinical decision-making and noninvasive assessments are insufficient or ambiguous. In acute decompensated heart failure, the PAC provides direct measurement of filling pressures (PCWP) and cardiac output, enabling the clinician to classify patients into Forrester hemodynamic profiles and titrate diuretics, vasodilators, and inotropes accordingly. Cardiogenic shock is a particularly important indication, as the PAC differentiates between low-output states caused by left ventricular failure, right ventricular failure, or mechanical complications such as acute mitral regurgitation or ventricular septal rupture.

In pulmonary vascular disease, the PAC is essential for confirming the diagnosis of pulmonary hypertension (mean PA pressure > 20 mmHg), classifying it as pre-capillary (PCWP ≤ 15 mmHg) or post-capillary (PCWP > 15 mmHg), and calculating pulmonary vascular resistance (PVR). The PAC also enables vasoreactivity testing with inhaled nitric oxide or intravenous prostacyclin, which determines candidacy for calcium channel blocker therapy in pulmonary arterial hypertension. Pre-operative hemodynamic assessment before cardiac transplantation or left ventricular assist device implantation represents another well-established indication, as elevated PVR may contraindicate orthotopic heart transplantation.

In the perioperative setting, PAC monitoring may be used during high-risk cardiac surgery, liver transplantation, and major vascular procedures to guide fluid management and vasoactive medication titration. Although randomized trials (notably the PAC-Man and ESCAPE studies) did not demonstrate a mortality benefit from routine PAC use, expert consensus supports targeted placement in patients with diagnostic uncertainty or complex hemodynamic derangements where the information obtained changes management. The key principle is that the PAC provides data — the clinical benefit depends on correct interpretation and appropriate therapeutic response to that data.

The PAC directly measures four pressure waveforms as it traverses the right heart: right atrial pressure (RAP, normal 2–8 mmHg mean), right ventricular pressure (RV systolic 15–30 mmHg, RV diastolic 2–8 mmHg), pulmonary artery pressure (PA systolic 15–30 mmHg, diastolic 4–12 mmHg, mean 9–18 mmHg), and pulmonary capillary wedge pressure (PCWP, normal 6–12 mmHg). These pressures allow calculation of the transpulmonary gradient (TPG = mPAP − PCWP, normal < 12 mmHg) and the diastolic pressure gradient (DPG = PA diastolic − PCWP, normal < 7 mmHg), which differentiate pre-capillary from post-capillary causes of elevated PA pressures.

Cardiac output is measured by thermodilution, with a normal resting value of 4.0 to 8.0 L/min. When indexed to body surface area (BSA), the cardiac index (CI) normally ranges from 2.5 to 4.0 L/min/m². The PAC also enables measurement of mixed venous oxygen saturation (SvO₂), with a normal range of 60–80%, reflecting the balance between oxygen delivery and consumption. An SvO₂ below 60% indicates inadequate oxygen delivery relative to demand and is an early warning sign of circulatory compromise, often preceding changes in blood pressure or heart rate. Continuous SvO₂ monitoring via fiber-optic PACs provides a real-time global indicator of hemodynamic adequacy.

Derived hemodynamic parameters calculated from PAC data include systemic vascular resistance (SVR = [MAP − CVP] / CO × 80), pulmonary vascular resistance (PVR = [mPAP − PCWP] / CO × 80), left ventricular stroke work index (LVSWI), and right ventricular stroke work index (RVSWI). These calculated variables provide insight into ventricular performance, afterload, and the response to therapeutic interventions. Serial measurements over hours or days are particularly valuable in the ICU for tracking hemodynamic trends and evaluating the effect of medication adjustments, fluid challenges, or mechanical circulatory support.

The PA catheter facilitates Fick cardiac output determination by providing access to mixed venous blood from the main pulmonary artery, which is the optimal sampling site for SvO₂ because it ensures complete mixing of venous return from the superior vena cava, inferior vena cava, and coronary sinus. Mixed venous blood drawn from the distal port of a properly positioned PAC reflects the weighted average oxygen saturation of all systemic venous return. Sampling from the right atrium or vena cava alone introduces error because oxygen saturations differ significantly between the upper body, lower body, and myocardial venous drainage.

To perform the Fick calculation, the clinician draws simultaneous arterial and mixed venous blood samples, measures hemoglobin concentration, and calculates arterial (CaO₂) and mixed venous (CvO₂) oxygen content using the standard formula: O₂ content = (1.34 × Hb × SO₂) + (0.003 × PO₂). Oxygen consumption (VO₂) is ideally measured by indirect calorimetry but is frequently estimated using body surface area-based assumptions. The Fick equation — CO = VO₂ / (CaO₂ − CvO₂) — then yields cardiac output in liters per minute. The PAC is the only bedside tool that provides both the mixed venous sample and the simultaneous hemodynamic pressure data needed for comprehensive Fick-based hemodynamic assessment.